Tenoxicam Ps.Inj.Sol 20mg/Vial (EU CTD Available)

Product Description

Tenoxicam 20 mg/Vial Powder for Solution for Injection Reference Product: Tilcitin® / Meda 
Description:  Tenoxicam is used in patients considered unable to take oral tenoxicam for the relief of pain and inflammation in osteoarthritis and rheumatoid arthritis and for the short-term management of acutemusculoskeletal disorders including strains, sprain sand other soft-tissue injuries.
Dossier Status: On-going / EU CTD Available
Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Three (3) years 
Batch Sizes: 27,000 vials
Pack Sizes: BT x 1 vial

ANFARM HELLAS S.A.

  • GR
  • 2015
    On CPHI since
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    Greece

ANFARM HELLAS S.A.

  • GR
  • 2015
    On CPHI since

More Products from ANFARM HELLAS S.A. (36)

  • Omeprazole Pd.Sol.Inf 40mg/vial (EU CTD Available)

    Product Omeprazole Pd.Sol.Inf 40mg/vial (EU CTD Available)

    Reference Product: Losec® / Astra Zeneca Powder for Solution for InfusionDescription: Omeprazole belongs to the ATC category of Proton-pump inhibitors which is a group of drugs whose main action is a pronounced and long-lasting reduction of stomach acid production.Due to their effective acid-suppressing ef...
  • Omeprazole Ps.Inj.Sol 40mg/vial (EU CTD Available)

    Product Omeprazole Ps.Inj.Sol 40mg/vial (EU CTD Available)

    Omeprazole 40mg/vial Powder for Solution for Injection  Reference Product: Losec® / Astra Zeneca
    Description: Omeprazole belongs to the ATC category of Proton-pump inhibitors which is a group of drugs whose main action is a pronounced and long-lasting reduction of stomach acid production.Due t...
  • Palonosetron Inj.Sol. 250mcg/5ml (Vial) (EU CTD Available)

    Product Palonosetron Inj.Sol. 250mcg/5ml (Vial) (EU CTD Available)

    Palonosetron 250mcg/5ml (Vial) Solution for Injection
    Reference Product: Aloxi® / Helsinn
    Description: Palonosetron is an antiemetic and antinauseant agent belonging to serotonin (5HT3) antagonists category.
    Palonosetron is indicated in adults and paediatric patients 1 month of age and older for t...
  • Pantoprazole Pd.Inj.Sol 40mg/Vial (EU CTD Available)

    Product Pantoprazole Pd.Inj.Sol 40mg/Vial (EU CTD Available)

    Pantoprazole 40 mg/Vial Powder for Solution for Injection
    Reference Product: Controloc® / Takeda
    Description: Pantoprazoleis a proton pump inhibitor indicated for the treatment of the Gastroesophageal Reflux Disease (GERD) with erosive esophagitis (EE) and in Pathological hypersecretion ...
  • Somatostatin Ps.Sol.Inf. 3mg/Vial (EU CTD Available)

    Product Somatostatin Ps.Sol.Inf. 3mg/Vial (EU CTD Available)

    Somatostatin 3mg/Vial Powder for Solution for Infusion
    Reference Product: Stilamin® / MSD Description: Somatostatin is indicated in cases of Growth Hormone Hypersecretion (ACROMEGALITY)
    Dossier Status: EU CTD Available
    Stability Studies: Zone II / Zone IVb
    Shelf life (Origi...
  • Sugammadex Inj.Sol. 100mg/ml (2 & 5 ml Vial) (EU CTD Available)

    Product Sugammadex Inj.Sol. 100mg/ml (2 & 5 ml Vial) (EU CTD Available)

    Sugammadex 100mg/ml (2 & 5 ml Vial) Solution for Injection
    Reference Product: Bridion® / MSD
    Description: Sugammadex is a modified gamma cyclodextrin which is a Selective Relaxant Binding Agent. 
    It forms a complex with the neuromuscular blocking agents rocuronium or vecuronium in plasma ...
  • Tigecycline Pd.Sol.Inf 50mg/Vial (EU CTD Available)

    Product Tigecycline Pd.Sol.Inf 50mg/Vial (EU CTD Available)

    Tigecycline 50 mg/Vial Powder for Solution for Infusion Reference Product: Tygacil® / Pfizer
    Description: Tigecycline, a glycylcycline antibiotic, inhibits protein translation in bacteria by binding to the 30S ribosomal subunitand blocking entry of amino-acyl tRNA molecules into the A site of the...
  • Vancomycin Pd.Sol.Inf 500mg/Vial (EU CTD Available) & 1g/vial (EU CT Available: Q3 2021)

    Product Vancomycin Pd.Sol.Inf 500mg/Vial (EU CTD Available) & 1g/vial (EU CT Available: Q3 2021)

    Vancomycin Vial Powder for Solution for Infusion
    Reference Product: Voncon® / Lilly
    Description: Vancomycin Hydrochloride is a glycopeptide antibacterial indicated in adult and pediatric patients (neonates and older) for the treatment of Septicemia, Infective Endocarditis, Ski...
  • Vildagliptin & Metformin Tabs (50+850 mg), (50+1000 mg) (EU CTD Available: Q3 2021)

    Product Vildagliptin & Metformin Tabs (50+850 mg), (50+1000 mg) (EU CTD Available: Q3 2021)

    Vildagliptin & Metformin(50+850 mg), (50+1000 mg) Film Coated Tablets Reference Product: Eucreas® / Novartis 
    Description: Vildagliptin & Metformin is a combination of 2 anti-diabetic agents indicated in the treatment of type 2 diabetes mellitus. More specifically, it is indicated...
  • Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available)

    Product Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available)

    Voriconazole 200 mg/Vial Powder for Solution for Infusion
    Reference Product: Vfend® / Pfizer
    Description: In the treatment of the following fungal infections: Invasive aspergillosis, Candidemia, Esophageal candidiasis, Serious fungal infections caused ...
  • Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)

    Product Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)

    Amikacin Solution for Injection 
    Reference Product: Briklin® / BRISTOL-MYERS SQUIBB
    Description: Amikacin sulfate is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species,&nb...
  • Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab  (under development)

    Product Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development)

    Apixaban Film Coated Tablets 2.5mg & 5mg
    Reference Product: Eliquis® / Bristol-Myers Squibb/Pfizer
    Description: Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transie...

ANFARM HELLAS S.A. resources (2)